Andrew Geyer

Identification of Novel Binding Interactions in the Development of Potent, Selective 2-Naphthamidine Inhibitors of Urokinase. Synthesis, Structural Analysis, and SAR of <i>N</i>-Phenyl Amide 6-Substitution

Michael Wendt, Todd W. Rockway, Andrew Geyer et al. · Journal of Medicinal Chemistry · 2003 · 66 citations · Full text

Discovery of a Series of Imidazo[4,5-<i>b</i>]pyridines with Dual Activity at Angiotensin II Type 1 Receptor and Peroxisome Proliferator-Activated Receptor-γ

Agustin Casimiro‐Garcia, Gary F. Filzen, Declan Flynn et al. · Journal of Medicinal Chemistry · 2011 · 52 citations · Full text

P2Y1 receptor antagonists as novel antithrombotic agents

Jeffrey A. Pfefferkorn, Chulho Choi, Thomas Winters et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 51 citations · Full text

Molecular Pharmacology, Platelet Aggregation Inhibitors, Thrombosis +8

Rasta Silanes:  New Silyl Resins with Novel Macromolecular Architecture via Living Free Radical Polymerization

Craig W. Lindsley, John C. Hodges, Gary F. Filzen et al. · Journal of Combinatorial Chemistry · 2000 · 41 citations

New Silyl Resins, Macromolecular Chemistry, Engineering +16

Interaction with the S1β-pocket of urokinase: 8-heterocycle substituted and 6,8-disubstituted 2-naphthamidine urokinase inhibitors

Michael Wendt, Andrew Geyer, William J. McClellan et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 28 citations · Full text

Molecular Pharmacology, Biochemistry, Medicine +7